Therapeutic Targeting of Macrophages and Neutrophils iconTherapeutic Targeting of Macrophages and Neutrophils

Therapeutic Targeting of Macrophages and Neutrophils

Sep 23, 2020 9:50am ‐ Sep 23, 2020 10:15am
MTL - CEBPA - Next Generation Immunotherapy Targeting Myeloid Cell Differentiation iconMTL - CEBPA - Next Generation Immunotherapy Targeting Myeloid Cell Differentiation

MTL - CEBPA - Next Generation Immunotherapy Targeting Myeloid Cell Differentiation

Sep 23, 2020 10:40am ‐ Sep 23, 2020 11:05am
Short Talk: Unravelling the Identity and Function of MDSC in Human Cancer Patients iconShort Talk: Unravelling the Identity and Function of MDSC in Human Cancer Patients

Short Talk: Unravelling the Identity and Function of MDSC in Human Cancer Patients

Sep 23, 2020 11:05am ‐ Sep 23, 2020 11:20am
Short Talk: Therapeutic Drugs Promote Differentiation of AML Blasts to a Mixed M1/M2 and Migratory Phenotype Resistant to Treatment Facilitated by the Bone Marrow Microenvironment. iconShort Talk: Therapeutic Drugs Promote Differentiation of AML Blasts to a Mixed M1/M2 and Migratory Phenotype Resistant to Treatment Facilitated by the Bone Marrow Microenvironment.

Short Talk: Therapeutic Drugs Promote Differentiation of AML Blasts to a Mixed M1/M2 and Migratory Phenotype Resistant to Treatment Facilitated by the Bone Marrow Microenvironment.

Sep 23, 2020 11:20am ‐ Sep 23, 2020 11:35am
Short Talk: Polarization of TAMs by Iron Nanoparticles as an Adjuvant Lung Cancer Therapy iconShort Talk: Polarization of TAMs by Iron Nanoparticles as an Adjuvant Lung Cancer Therapy

Short Talk: Polarization of TAMs by Iron Nanoparticles as an Adjuvant Lung Cancer Therapy

Sep 23, 2020 11:35am ‐ Sep 23, 2020 11:50am
Poster Session 3 iconPoster Session 3

Poster Session 3

Sep 23, 2020 2:30pm ‐ Sep 23, 2020 4:00pm
Targeting PI3K-gamma with IPI-549, a Tumor Macrophage-Reprogramming Small Molecule, in Patients with Advanced Solid Tumors iconTargeting PI3K-gamma with IPI-549, a Tumor Macrophage-Reprogramming Small Molecule, in Patients with Advanced Solid Tumors

Targeting PI3K-gamma with IPI-549, a Tumor Macrophage-Reprogramming Small Molecule, in Patients with Advanced Solid Tumors

Sep 23, 2020 4:00pm ‐ Sep 23, 2020 4:25pm
Targeting Myeloid Cells in Cancer Therapy II iconTargeting Myeloid Cells in Cancer Therapy II

Targeting Myeloid Cells in Cancer Therapy II

Sep 23, 2020 4:00pm ‐ Sep 23, 2020 7:00pm
Differentiating Macrophages are Regulated by PARP Inhibitors and can be Harnessed to Overcome PARP-Inhibitor Resistance in BRCA-Associated Triple-Negative Breast Cancer iconDifferentiating Macrophages are Regulated by PARP Inhibitors and can be Harnessed to Overcome PARP-Inhibitor Resistance in BRCA-Associated Triple-Negative Breast Cancer

Differentiating Macrophages are Regulated by PARP Inhibitors and can be Harnessed to Overcome PARP-Inhibitor Resistance in BRCA-Associated Triple-Negative Breast Cancer

Sep 23, 2020 4:25pm ‐ Sep 23, 2020 4:50pm
Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer Progression iconArming Tumor-Associated Macrophages to Reverse Epithelial Cancer Progression

Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer Progression

Sep 23, 2020 4:50pm ‐ Sep 23, 2020 5:15pm